Convalescent Plasma May Cut Deaths in Hematologic Cancer and COVID-19

MONDAY, June 21, 2021 -- For hospitalized patients with hematologic cancers and COVID-19, convalescent plasma therapy is associated with lower 30-day mortality, according to a study published online June 17 in JAMA Oncology. Michael A. Thompson,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news